LEADER 00899nam0-22002891i-450-
001 990008494210403321
005 20070828125951.0
010   $a0-935404-67-8
035   $a000849421
035   $aFED01000849421
035   $a(Aleph)000849421FED01
035   $a000849421
100   $a20070328d1987----km-y0itay50------ba
101 0 $aeng
200 1 $aAldose reductase inhibition$ean approach to the prevention of diabetic complications$fDushan Dvornik, Daniel Porte
210   $aNew York$cBiomedical Information Corporation$d1987
215   $aXI, 368 p.$cill.$d23 cm
610 0 $aDiabete$aTerapia
700  1$aDvornik,$bDushan$0302626
701  1$aPorte,$bDaniel$0302627
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990008494210403321
952   $a616.379-008.64 DVO$b959$fDMECM
959   $aDMECM
996   $aAldose reductase inhibition$9731227
997   $aUNINA